Chromatographic method validation: A review of current practices and procedures. I. General concepts and guidelines

Journal of Liquid Chromatography and Related Technologies

Volumn 19, Issue 5, 1996, Pages 719-736

  Jenke, Dennis R ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALIBRATION; CHROMATOGRAPHY; DRUG CONTROL; DRUG DEVELOPMENT; QUANTITATIVE ASSAY; TECHNIQUE;

EID: 0029986001     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826079608005533     Document Type: Article

References (49)

1. "Guideline for Submitting Samples and Analytical Data for Methods Validation." US Department of Health and Human Services, Food and Drug Administration, Maryland, USA, Feb. 1987.
2. United States Pharmacopeia 23. Section 1225, "Validation of Compendial Methods." United States Pharmacopeia Convention Inc., Rockville, MD, 1995, pp. 1982-1984.
3. Department of Health Medicines Act 1968, Guidance Notes on Applications of Product Licenses (MAL2) A20-7 and A2E-2. HMSO, 1987.
4. "Committee for Proprietary Medicinal Products Guidance Note on Analytical Validation," Final Draft, Document No. 111/844/87-EN, Aug, 1989.
5. "Guidelines on the Quality, Safety and Efficacy of Medical Products for Human Use in The Rules Governing Medical Products in the European Community." Volume III. Addendum July 1990.
6. "Health Protection Branch, Acceptable Methods, Drugs Directorate Guidelines." Minister of Health and Welfare, Canada, 1992.
7. "Reviewer Guidance. Validation of chromatographic Methods." Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD, Nov, 1994.
8. "International Conference on Harmonization; Guideline on Validation of Analytical Procedures: Definitions and Terminology; Availability." US Department of Health and Human Services (HHS). Federal Register, 60(40), 11260-11265 (March 1, 1995).
9. J. C. Wahlich, G. P Carr, J. Pharm. Biomed. Anal., 8, 619-623 (1990).
10. Code of Federal Regulations (21 CFR), Foods and Drugs, Parts 200 to 299, April 1, 1994.
11. E. B. Sheinin, Pharm. Technol., 10 (Sept), 82-96 (1986).
12. E. Debesis, J. P. Boehlert, T. E. Givand, J. C. Sheridan, Pharm. Technol, 6(9), 120-137 (1982).
13. A. J. Vanderwielen, E. A. Hardwidge, Pharm. Technol, 6(3), 66-76 (1982).
14. S. M. Ficarro, K. A. Shah, Pharm. Manuf., 1984 (Sept), 25-27 (1984).
15. J. Guerra, Pharm. Technol., 10(3), 74-78 (1986).
16. M. J. Finkelson, Pharm. Technol., 10(3), 75-84 (1986).
17. D. R. Williams, BioPharm, 5(Nov), 34-36, 51 (1987).
18. A. C. Mehta, Talanta, 34, 609-613 (1987).
19. E. L. Inman, J. K. Frischmann, P. J. Jimenez, G. D. Winkel, M. L. Persinger, B. S. Rutherford, J. Chromatogr. Sci., 25, 252-256 (1987).
20. W. G. DeRuig, R. W. Stephany, G. Dijkstra, J. A. O. A. C., 72, 487-490 (1989).
21. A. C. Mehta, J. Clin. Pharm. Ther., 14, 465-473 (1989).
22. G. Szepesi, M. Gazdag, K. Mihalyfi, J. Chromatogr., 464, 265-278 (1989).
23. H. B. S. Conacher, J. A. O. A. C., 7, 332-334 (1990).
24. L. M. C. Buydens, J. A. van Leeuwen, M. Mulholland, B. G. M. Vandeginste, G. Kateman. TRAC, 9(2), 58-62 (1990).
25. P. A. D. Edwardson, G. Bhaskar, J. E. Fairbrother, J. Pharm. Biomed. Anal., 8, 629-637 (1990).
26. A. R Buick. M. V. Doig, S. C. Jeal, G. S. Land, R. D. McDowall, J. Pharm. Biomed. Anal., 8, 629-637 (1990).
27. M. J. Cardone, S. A. Willavize, M. E. Lacy, Pharm. Res., 7, 154-160 (1990).
28. T. D. Wilson, J. Pharm. Biomed. Anal., 8, 389-400 (1990).
29. M. W. Dong, P. V. Passalacqua, D. P. Choudhury, J. Liq. Chroamtogr. 13, 2135-2160 (1990).
30. W. L. Paul, Pharm. Technol., 15(March), 130-160 (1991).
31. J. R. Lang, S. Bolton, J. Pharm. Biomed Anal., 9, 357-361 (1991).
32. J. R. Lang, S. Bolton, J. Pharm. Biomed. Anal., 9, 435-442 (1991).
33. C. Desain, BioPharm., 15, 30-34 (1992).
34. R. F. Tefzlaff, Pharm. Technol., 16(May), 70-83 (1992).
35. V. P. Shah, J. Pharm. Sci., 81, 309-312 (1992).
36. A. A. Priestner, Anal Proceed., 30, 374-377 (1993).
37. G. C. Hokanson, Pharm Tech., 18(Sept), 118-130 (1994).
38. G. C. Hokanson, Pharm. Tech., 18(Oct), 92-100 (1994).
39. D. L. Massart, J. Smeyers-Verbeke. B. Vandeginste, Analusis, 22, M14-M16 (1994).
40. C. Hartmann, Analusis, 22, M19-M21 (1994).
41. W. Penninckx, Analusis, 22, M22-M23 (1994).
42. L. A. Currie, W. Horwitz, Analusis, 22, M24-M26 (1994).
43. Y. Vander Heyden, Analusis, 22, M27-M29 (1994).
44. M. Feinberg, Analusis, 22, M34-M37 (1994).
45. D. Dadgar, P. E. Burnett, M. G. Choc, K. Gallicano, J. W. Hopper, J. Pharm. Biomed. Anal., 13, 89-97 (1995).
46. T. O'Shea, PEAK (Hewlett Packard), 1995(1), 1-3 (1995).
47. W. Horwitz, ChemTech, 1994(March), 186-191 (1994).
48. J. K. Taylor, Anal. Chem., 55, 600A-608A (1983).
49. G. S. Clarke, J. Pharm. Biomed. Anal., 12, 643-652 (1994).